Cargando…

Developing and delivering a hybrid Cardiac Rehabilitation Phase II exercise program during the COVID-19 pandemic: a quality improvement program

The COVID-19 pandemic resulted in the cessation of approximately 75% of cardiac rehabilitation (CR) programmes worldwide. In March 2020, CR phase II (CRP2) services were stopped in Qatar. Multiple studies had shown safety, effectiveness, reduced cost of delivery and improved participation with hybri...

Descripción completa

Detalles Bibliográficos
Autores principales: Loureiro Diaz, Javier, Foster, Liam David, Surendran, Praveen Jayaprabha, Jacob, Prasobh, Ibrahim, Omar, Gupta, Poonam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254689/
https://www.ncbi.nlm.nih.gov/pubmed/37257915
http://dx.doi.org/10.1136/bmjoq-2022-002202
_version_ 1785056702632034304
author Loureiro Diaz, Javier
Foster, Liam David
Surendran, Praveen Jayaprabha
Jacob, Prasobh
Ibrahim, Omar
Gupta, Poonam
author_facet Loureiro Diaz, Javier
Foster, Liam David
Surendran, Praveen Jayaprabha
Jacob, Prasobh
Ibrahim, Omar
Gupta, Poonam
author_sort Loureiro Diaz, Javier
collection PubMed
description The COVID-19 pandemic resulted in the cessation of approximately 75% of cardiac rehabilitation (CR) programmes worldwide. In March 2020, CR phase II (CRP2) services were stopped in Qatar. Multiple studies had shown safety, effectiveness, reduced cost of delivery and improved participation with hybrid CR. A multidisciplinary team reviewed various alternative models for delivery and decided to implement a hybrid CRP2 exercise programme (HCRP2-EP) to ensure continuation of our patient care. Our aim was to enrol in the HCRP2-EP 70% of all eligible patients by 30 September 2020. Institute for Health Care Improvement’s collaborative model was adopted. Multiple plan–do–study–act cycles were used to test change ideas. The outcomes of the project were analysed using standard run chart rules to detect the changes in outcomes over time. This project was implemented from March 2020, and the male patients enrolled between August 2020 and April 2021, with sustained monthly median enrolment above target of 70% throughout. As for our secondary outcome, 75.8% of the male patients who completed HCRP2-EP showed a meaningful change in peak exercise capacity of ≥10% (mean change 17%±6%). There were no major adverse events reported, and the median Patient Satisfaction Score was 96% well above the institutional target of 90%. This shows a well-designed quality improvement programme is an appropriate strategy for implementing HCRP2-EP in a clinical setting, and HCRP2-EP is a feasible, effective and safe intervention in eligible male patients with cardiovascular disease.
format Online
Article
Text
id pubmed-10254689
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-102546892023-06-10 Developing and delivering a hybrid Cardiac Rehabilitation Phase II exercise program during the COVID-19 pandemic: a quality improvement program Loureiro Diaz, Javier Foster, Liam David Surendran, Praveen Jayaprabha Jacob, Prasobh Ibrahim, Omar Gupta, Poonam BMJ Open Qual Quality Improvement Programme The COVID-19 pandemic resulted in the cessation of approximately 75% of cardiac rehabilitation (CR) programmes worldwide. In March 2020, CR phase II (CRP2) services were stopped in Qatar. Multiple studies had shown safety, effectiveness, reduced cost of delivery and improved participation with hybrid CR. A multidisciplinary team reviewed various alternative models for delivery and decided to implement a hybrid CRP2 exercise programme (HCRP2-EP) to ensure continuation of our patient care. Our aim was to enrol in the HCRP2-EP 70% of all eligible patients by 30 September 2020. Institute for Health Care Improvement’s collaborative model was adopted. Multiple plan–do–study–act cycles were used to test change ideas. The outcomes of the project were analysed using standard run chart rules to detect the changes in outcomes over time. This project was implemented from March 2020, and the male patients enrolled between August 2020 and April 2021, with sustained monthly median enrolment above target of 70% throughout. As for our secondary outcome, 75.8% of the male patients who completed HCRP2-EP showed a meaningful change in peak exercise capacity of ≥10% (mean change 17%±6%). There were no major adverse events reported, and the median Patient Satisfaction Score was 96% well above the institutional target of 90%. This shows a well-designed quality improvement programme is an appropriate strategy for implementing HCRP2-EP in a clinical setting, and HCRP2-EP is a feasible, effective and safe intervention in eligible male patients with cardiovascular disease. BMJ Publishing Group 2023-05-31 /pmc/articles/PMC10254689/ /pubmed/37257915 http://dx.doi.org/10.1136/bmjoq-2022-002202 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Quality Improvement Programme
Loureiro Diaz, Javier
Foster, Liam David
Surendran, Praveen Jayaprabha
Jacob, Prasobh
Ibrahim, Omar
Gupta, Poonam
Developing and delivering a hybrid Cardiac Rehabilitation Phase II exercise program during the COVID-19 pandemic: a quality improvement program
title Developing and delivering a hybrid Cardiac Rehabilitation Phase II exercise program during the COVID-19 pandemic: a quality improvement program
title_full Developing and delivering a hybrid Cardiac Rehabilitation Phase II exercise program during the COVID-19 pandemic: a quality improvement program
title_fullStr Developing and delivering a hybrid Cardiac Rehabilitation Phase II exercise program during the COVID-19 pandemic: a quality improvement program
title_full_unstemmed Developing and delivering a hybrid Cardiac Rehabilitation Phase II exercise program during the COVID-19 pandemic: a quality improvement program
title_short Developing and delivering a hybrid Cardiac Rehabilitation Phase II exercise program during the COVID-19 pandemic: a quality improvement program
title_sort developing and delivering a hybrid cardiac rehabilitation phase ii exercise program during the covid-19 pandemic: a quality improvement program
topic Quality Improvement Programme
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254689/
https://www.ncbi.nlm.nih.gov/pubmed/37257915
http://dx.doi.org/10.1136/bmjoq-2022-002202
work_keys_str_mv AT loureirodiazjavier developinganddeliveringahybridcardiacrehabilitationphaseiiexerciseprogramduringthecovid19pandemicaqualityimprovementprogram
AT fosterliamdavid developinganddeliveringahybridcardiacrehabilitationphaseiiexerciseprogramduringthecovid19pandemicaqualityimprovementprogram
AT surendranpraveenjayaprabha developinganddeliveringahybridcardiacrehabilitationphaseiiexerciseprogramduringthecovid19pandemicaqualityimprovementprogram
AT jacobprasobh developinganddeliveringahybridcardiacrehabilitationphaseiiexerciseprogramduringthecovid19pandemicaqualityimprovementprogram
AT ibrahimomar developinganddeliveringahybridcardiacrehabilitationphaseiiexerciseprogramduringthecovid19pandemicaqualityimprovementprogram
AT guptapoonam developinganddeliveringahybridcardiacrehabilitationphaseiiexerciseprogramduringthecovid19pandemicaqualityimprovementprogram